BSEAmkay Products LtdHighNeutral
Announced Thu, 28 May · 17:58 IST

Audited financial result for the half year and year ended March 31, 2026

Pat NegativeEbitda Margin CompressionResults View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-9.0%1-day move
₹61.00
prior close
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-9.0-9.0-6.8-4.9
Up moveDown movePending
AI summary

Amkay Products Ltd reported revenue from operations of Rs 4,202.70 lakhs for FY26, up 9.5% from Rs 3,839.01 lakhs in FY25. However, profit after tax declined significantly to Rs 231.10 lakhs from Rs 333.85 lakhs in the previous year, a drop of about 31%. EBITDA margin compressed from 13.7% to 10.6% due to higher raw material costs and employee expenses. The company operates in two segments: manufacturing and trading of medical devices and consumables. The statutory auditor issued an unmodified opinion, and the board also approved appointment of M/s. Soni Punit & Associates as internal auditor for FY27.

Likely market impact

The 31% decline in net profit despite revenue growth signals margin pressure from rising input costs. Shareholders should monitor whether this trend continues, as EBITDA margins have contracted meaningfully.